Trulieve Cannabis Corp., a leading and top-performing cannabis company in the United States, announced it has been named a winner of a Silver Stevie® Award for Achievement in Growth in the 19th Annual American Business Awards®. The awards recognize businesses that have excelled in further developing their operations through various avenues such as mergers and acquisitions and corporate expansion.

"After an unprecedented 2020, we are proud to be recognized for our growth and expansion into new markets," said Kim Rivers, CEO of Trulieve. "We look forward to building on this momentum as we drive further expansion across North America, including operations in Pennsylvania and the opening of Massachusetts in our northeast hub, bringing our high-quality cannabis products and unmatched customer service to more patients and consumers."


As longtime partners in education, healthcare, wellness, community engagement and more, Lee Health and Florida SouthWestern State College (FSW) have entered into a letter of intent to further grow the partnership and create new opportunities for students in our region.

Through the collaborative relationship, Lee Health and FSW plan to develop several initiatives designed to benefit students, Lee Health team members and the Southwest Florida community.
 
Lee Health and FSW will create different learning programs and internships for FSW students that will prepare them for potential job opportunities within Lee Health and provide a pipeline of highly qualified and trained employees to serve Southwest Florida.
 
Additionally, Lee Health and FSW will develop programs to engage Lee Health staff in the activities of the college, along with continuing to provide support to current and future FSW School of Health Professions programs, including nursing, respiratory care, cardiopulmonary sciences, radiologic technology and more.
 
Lee Health is currently the largest employer of graduates from the FSW School of Health Professions in the areas of nursing, EMT, respiratory care and other programs.
 

Through the partnership, Lee Health and FSW will continue to support undergraduate studies of nursing and a variety of clinical specialties offered by FSW as a primary clinical site for training.



Delray Medical Center is the first and only hospital in Southern Palm Beach County now offering the NAVIO orthopedic surgical system to help surgeons perform precise and accurate partial and total knee replacement surgeries using the JOURNEY UNI knee. This technology for partial and total knee replacements uses a CT-free intra-operative registration, planning and navigation platform to assist the surgeon in building patient specific surgical plans.

Some of the potential benefits for this type of surgery include:
• Does not require a pre-operative CT scan
• Fewer doctor office visits to prep for surgery
• Minimally-invasive
• Freehand sculpting intended to allow for better precision and accuracy
• Designed to have less pain and swelling post-operatively-Can lead to faster recovery times


To more effectively treat emerging variants of COVID-19, and in accordance with NIH guidelines, Broward Health has revised its monoclonal antibody therapy and has started using a combination of bamlanivimab and etesevimab, which has been approved by the FDA under an Emergency Use Authorization (EUA). This new combination has shown promising results over the single agent bamlanivimab, which was previously used solely, at addressing COVID-19 infection due to some variants.

“Broward Health continues to explore the most effective treatments for our patients as the COVID-19 virus mutates,” said Joshua Lenchus, D.O., chief medical officer, Broward Health Medical Center. “Monoclonal antibodies have proven effective in preventing COVID-positive patients from getting very sick and requiring hospitalization. But now, as we see the increase in COVID variants affecting our community, we must modify our therapies to ensure the best possible outcomes for our patients.”
 
Administered together as a diluted intravenous infusion, this new combination can be used for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing. Patients must be 12 years of age and older weighing at least 40 kg and be at high risk for progressing to severe COVID-19 and/or hospitalization. Monoclonal antibody therapy is available in the outpatient setting.
 
 


Delray Medical Center is the first hospital in South Florida to use the Synaptive’s Modus V™ 3D exoscope. This technology is a fully automated, robotic digital microscope combining advanced optics with 3D visualization, video processing and robotic automation allowing for a more precise excision of brain tumors. The hospital is also the first hospital in South Florida to use the Modus V™ 3D for spinal surgery. Utilizing voice-control surgeons can maintain focus at all times on the surgical field.

“This new technology is designed to offer improved procedural outcomes for patients, and give us the best opportunity to safely operate on the brain and spine,” said Dr. Lloyd Zucker, medical director of neurosurgery for Delray Medical Center. “We look forward to bringing these benefits to our patients at Delray Medical Center. The hospital is committed to bringing this and other groundbreaking technologies to South Florida.”
 
Unlike traditional microscopes, Modus V allows all members of the operating room team to see the magnified surgical field in 3D, which is displayed on a screen. At the same time the surgeon is viewing it in 3D. The Modus V provides a larger depth of field and magnification than a conventional operating microscope.
 
The video exoscope provides the clinician with auto-focus and voice-activated controls. This allows control of the camera position and all other camera functions hands-free, so the surgeon can keep operating at all times with better visualization and navigation.